Olatoyosi Odenike

University of Chicago — United States

Medicine · Health Sciences

45h-index9.9kcitations354works2.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(203), Chronic Myeloid Leukemia Treatments(99), Acute Lymphoblastic Leukemia research(91), Myeloproliferative Neoplasms: Diagnosis and Treatment(89), Chronic Lymphocytic Leukemia Research(48)

Publications354 total

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms
Blood Advances·2026Open Access
Supplementary Table 1 from Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
2025Open Access
Supplementary figures 1-9 from Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
2025Open Access
<i>IDH2</i> mutation is associated with favorable outcome among older adults with newly diagnosed acute myeloid leukemia treated with hypomethylating agent-based therapy
Haematologica·2025· 1 citedOpen Access
Updated response and safety analyses from a Phase 1 study of ivosidenib combined with intensive chemotherapy in patients with newly diagnosed (ND) Acute Myeloid Leukemia with isocitrate dehydrogenase (IDH)1 mutation
Blood·2025
Primary efficacy analysis of phase II study investigating tyrosine kinase inhibitor (TKI) and inotuzumab ozogamicin-based therapy for newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
Blood·2025Open Access
Abstract 4372348: Characterization and Prognostic Implications of Pulmonary Hypertension on Right Heart Catheterization Among Patients with Myeloproliferative Neoplasms
Circulation·2025
Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study
Blood·2025Open Access
Low-dose oral decitabine and cedazuridine among patients with low-risk myelodysplastic syndromes
Blood·2025
Spiritual wellness and quality-of-life in adult patients with newly diagnosed acute leukemia receiving initial therapy: Patient-reported outcomes (PROs) from a prospective observational study
Blood·2025Open Access
Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms
Blood·2025Open Access
The impact of environmental air exposues on disease characteristics and outcomes in a cohort of patients with myelofibrosis
Blood·2025Open Access
Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis
Blood·2025
A dynamic comprehensive geriatric assessment demonstrates improvement in patient fitness after induction and predicts survival and treatment tolerability among older adults with newly diagnosed acute myeloid leukemia
Blood·2025Open Access
Trial in progress – a phase 1b trial of ivosidenib combined with ruxolitinib in IDH1-mutated advanced myeloproliferative neoplasms
Blood·2025Open Access
Trial in progress: A Phase I/II study to investigate the combination of LP-118, ponatinib, vincristine and dexamethasone (LPVd regimen) in relapsed/refractory T-ALL/lbl
Blood·2025Open Access
RAS mutations negate the favorable impact of NPM1 in older patients with newly diagnosed Acute Myeloid Leukemia treated with ven/HMA
Blood·2025Open Access
Myeloid malignancies molecular analysis for therapy choice (myeloMATCH): Rapid availability of clinical, pathologic and molecular features for treatment assignment in the first 550 patients.
Blood·2025
Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms
Blood·2025
Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms
Blood·2025Open Access
page 1 of 18Next →

Frequent Co-authors

Wendy Stock(17), Richard A. Larson(14), Guillermo Garcia‐Manero(11), Lucy A. Godley(9), Andrew Artz(9), Hagop M. Kantarjian(8), Michael R. Savona(7), Koen van Besien(6), Daniel A. Pollyea(6), Prapti A. Patel(6), Uma Borate(6), Andrew H. Wei(5), Srđan Verstovšek(5), H. Joachim Deeg(5), James McCloskey(5), Amy E. DeZern(5), Amer M. Zeidan(5), Jacqueline S. Garcia(5), Richard M. Stone(4), Martin S. Tallman(4)